Quoin Pharmaceuticals Analyst Ratings
Quoin Pharmaceuticals Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/07/2022 | 502.41% | Alliance Global Partners | → $20 | Initiates Coverage On | → Buy |
| 05/06/2022 | -39.76% | Ladenburg Thalmann | → $2 | Initiates Coverage On | → Buy |
| 01/07/2022 | 50.6% | Maxim Group | → $5 | Initiates Coverage On | → Buy |
| 12/15/2021 | 140.96% | JMP Securities | → $8 | Initiates Coverage On | → Market Outperform |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 09/07/2022 | 502.41% | 联盟全球合作伙伴 | → 20 美元 | 启动覆盖范围开启 | → 购买 |
| 2022 年 6 月 5 日 | -39.76% | 拉登堡塔尔曼 | → 2 美元 | 启动覆盖范围开启 | → 购买 |
| 2022 年 7 月 1 日 | 50.6% | Maxim 集团 | → 5 美元 | 启动覆盖范围开启 | → 购买 |
| 2021 年 12 月 15 日 | 140.96% | JMP 证券 | → 8 美元 | 启动覆盖范围开启 | → 市场跑赢大盘 |
Quoin Pharmaceuticals Questions & Answers
Quoin Pharmicals 问答
The latest price target for Quoin Pharmaceuticals (NASDAQ: QNRX) was reported by Alliance Global Partners on September 7, 2022. The analyst firm set a price target for $20.00 expecting QNRX to rise to within 12 months (a possible 502.41% upside). 4 analyst firms have reported ratings in the last year.
联盟全球合作伙伴于2022年9月7日公布了Quoin制药（纳斯达克股票代码：QNRX）的最新目标股价。该分析公司将目标股价定为20.00美元，预计QNRX将在12个月内升至12个月内（可能上涨502.41％）。去年有4家分析公司公布了评级。
The latest analyst rating for Quoin Pharmaceuticals (NASDAQ: QNRX) was provided by Alliance Global Partners, and Quoin Pharmaceuticals initiated their buy rating.
Quoin Pharmicals（纳斯达克股票代码：QNRX）的最新分析师评级由联盟全球合作伙伴提供，Quoin Pharmicals启动了买入评级。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Quoin Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Quoin Pharmaceuticals was filed on September 7, 2022 so you should expect the next rating to be made available sometime around September 7, 2023.
分析师在进行了广泛的研究后得出了股票评级，其中包括浏览公开财务报表，与Quoin Pharmicals的高管和客户交谈，以及听取财报电话会议。大多数分析师每三个月做一次这样的评级，因此每家公司每年应该获得4次评级。Quoin Pharmicals的最新评级是在2022年9月7日发布的，因此您应该预计下一个评级将在2023年9月7日左右公布。
While ratings are subjective and will change, the latest Quoin Pharmaceuticals (QNRX) rating was a initiated with a price target of $0.00 to $20.00. The current price Quoin Pharmaceuticals (QNRX) is trading at is $3.32, which is within the analyst's predicted range.
尽管评级是主观的，并且会发生变化，但最新的Quoin Pharmicals（QNRX）评级是启动的，目标股价为0.00美元至20.00美元。Quoin Pharmicals（QNRX）目前的交易价格为3.32美元，在分析师的预测区间内。